Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)
复制标题
DOI：
10.1016/j.jsat.2005.01.006
复制
发表时间：
2005-04-01
影响因子：
3.9
通讯作者：
Lynskey, M
中科院分区：
文献类型：
--
作者：
Darke, S;Ross, J;Lynskey, M
目的：确定与实现持续海洛因戒断相关的治疗和客户特征的作用。设计：纵向队列研究。背景：澳大利亚悉尼和阿德莱德。参与者：570名海洛因使用者在澳大利亚治疗结果研究（ATOS）的12个月随访时再次接受采访。结果：14%的参与者报告了持续的海洛因戒断。持续戒烟与既往无治疗史、基线时已进入治疗和随访期间的累积治疗暴露相关。指数维持和住院康复治疗中较长的保留时间（而不是解毒）与禁欲最相关。在基线时，禁欲的参与者更有可能被归类为准备好治疗，或者使用海洛因的频率较低;并且不太可能每天注射，使用可卡因或参与犯罪。结论：大约14%的ATOS参与者在12个月内实现了连续的海洛因戒断。这一成就与更长的治疗“结束”时间以及随访期间更高的治疗稳定性密切相关。(c)2005年爱思唯尔公司All rights reserved.
Aims: To determine the role of treatment and client characteristics associated with the achievement of continuous heroin abstinence. Design: Longitudinal cohort study. Setting: Sydney and Adelaide, Australia. Participants: 570 heroin users re-interviewed at 12 month follow-up for the Australian Treatment Outcome Study (ATOS). Findings: Continuous heroin abstinence was reported by 14% of participants. Continuous abstinence was associated with no previous treatment history, having entered treatment at baseline, and cumulative treatment exposure over the follow-up period. Longer retention times in index maintenance and residential rehabilitation treatments, but not detoxifications, were most associated with abstinence. At baseline, abstinent participants were more likely to have been classified as treatment ready, or to have used heroin less frequently; and less likely to have been daily injectors, using cocaine or criminally involved. Conclusions: Approximately 14% of ATOS participants achieved continuous heroin abstinence over 12 months. Such an achievement was strongly associated with a longer "close" of treatment, and with more treatment stability over the follow-up period. (c) 2005 Elsevier Inc. All rights reserved.